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Abstract
Biofilm formation in clinical settings is an increasingly important issue particu-
larly due to the emergence of multidrug-resistant strains, as it resulted in increased 
mortality, which poses a considerable financial burden on healthcare systems. The 
bacterial biofilms are quite resistant to the routine antimicrobial-based therapies; 
therefore, the novel strategies are desired in addition to the conventional antibiot-
ics for the effective control of infections caused by biofilm-forming microbes. So 
far, the approaches being proposed to control the biofilm formation in clinical 
practice settings include the use of biofilm inhibitors and the use of modified 
biomaterials for the development of medical devices to thwart the formation 
of biofilms. In this chapter, we have focused on the latest developments in the 
anti-biofilm strategies through the interruption of the quorum-sensing system, 
which is crucial for biofilm formation and have summarized the various classes 
of antibacterial compounds for the control of biofilm formation. This agrees with 
the recent approaches suggested by the National Institute of Health (NIH) that 
advocates the use of combinational therapies based on the conventional methods 
and complementary treatment to explore the potential utility and safety concerns 
of the natural products. The studies regarding these emerging strategies could 
possibly lead to the establishment of better therapeutic alternates compared to 
conventional treatments.
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1. Introduction
Group of microbial cells that are surface-attached and embedded within the 
extracellular matrix (self-produced), and are strikingly resistant to antimicrobials 
are called biofilms [1]. Biofilms can adhere to almost different types of surfaces like 
body tissue and plant, plastics, metals, implant objects as well as medical devices [2]. 
Formation of biofilm on implants and medical equipment and implants, for example, 
vascular grafts, prosthetic joints, heart valves, catheters, intrauterine devices, pace-
makers, and contact lenses can cause infection. Central line-associated bloodstream 
infection (CLABSI) can occur due to use of intravascular catheters, furthermore, 
Bacterial Biofilms
2
CLABSI can cause an increased rate of mortality and morbidity, and every year in the 
USA almost 250,000 cases of bloodstream infections are reported [3].
When cells adhere and attach to surfaces biofilm formation begins. Several 
factors can promote the attachment of microorganisms to biomaterials including 
increased shear forces, bacterial motility, and electrostatic as well as hydro-
dynamic interactions between the surface and microbial cells [4]. It has been 
observed that adherence of biomaterials to bacteria via biomaterial-surface 
interactions and cell-surface is facilitated by numerous factors, such as protein 
autolysin, surface, and adhesion proteins and capsular polysaccharides, etc. 
For example, ‘Staphylococcus species’ show cell-surface proteins that are vital 
for adherence of ‘Staphylococcus epidermidis’ to polystyrene which is named as 
staphylococcal surface protein-1 and -2 (SSP-1 and SSP-2). After attachment 
to the extracellular surfaces, microbial cells will start aggregate, multiply, and 
eventually differentiate into the biofilm network [5]. Such microbial cells can then 
be separated from mature biofilms, can cause chronic infections and can spread to 
other organs also [6].
Another worrying characteristic of infections associated with biofilm for-
mation is increased biofilm cell tolerance to biocides. As biofilms provide an 
excellent niche for exchange of plasmid, so increased resistance to the drug can 
affect genes containing plasmids which results in multidrug resistance (MDR) 
phenotypes. Enhanced drug resistance mechanisms include incomplete or slow 
infiltration of antimicrobials within the extracellular matrix, the formation of 
dormant cells during the non-dividing phase, reduced cell’s growth rate within the 
biofilm, hence ultimately decreasing total targets for antimicrobial molecules [7]. 
Furthermore, it is difficult to treat biofilm formation with the traditional antimi-
crobial approach and the therapy is further inhibited by increased resistance to 
the antibiotic because under antibiotic selective pressure microbial cells develop 
resistance. For instance, it has been observed that almost above 70% of hospital 
isolate of ‘Staphylococcus epidermidis’ show resistance to methicillin and surpris-
ingly there are many strategies to prevent infections associated with biofilm 
formation other than antibiotic treatment [8]. In this chapter, we have focused on 
anti-biofilm approaches and some promising efforts for controlling these biofilm-
based infections.
2. The process of biofilm development
The production and maturation of biofilm are complex, subsequent and 
dynamic processes, depending upon several factors i.e. cellular metabolism, 
intrinsic properties of the cells, genetic control, the substratum, and the medium 
signaling molecules. Biofilm formation is introduced with a conditioning film 
of inorganic or organic material on the cell surface; furthermore, this layer 
modifies the surface feature of substratum which ultimately favors microbes 
for colonization on the cell surface. The formation of biofilm consist of several 
different steps: (i) initially the reversible attachment of microbial cells with 
biotic or abiotic surfaces through weak forces for example van der Waals forces, 
(ii) irreversible attachment to the cell surface with the help of different attach-
ment structure i.e. lipopolysaccharides, flagella, adhesive proteins or fimbriae 
by hydrophobic or hydrophilic interactions, (iii) and then eventually biofilm 
architecture development due to the production and proliferation of extracellular 
polysaccharide (EPS) matrix which is self-produced and is made up of proteins, 
extracellular deoxyribonucleic acid (DNA) and polysaccharides [9] (iv) in the 
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next step mature biofilm is formed which has water channels that are responsible 
for distribution of nutrients as well as signaling molecules within the biofilm 
[10], (v) and then due to extrinsic or intrinsic factors separation of biofilm cells 
occurs individually or in clumps and finally colonization of other niches and 
dispersal of the cells [11].
3. Inhibition of initial attachment
3.1 Altering physical properties of biomaterials
Biofilm development starts with a reversible weak adhesion of microbial cells 
to the exterior surface of medical equipment, however, if they are not removed 
from the exterior of devices, they adhered permanently through their adhesion 
structures i.e. fimbriae, pili and thereby forming biofilm matrix [12]. Surface 
charge and hydrophobicity of implant constituents play a significant role in con-
trolling the ability of microbes to anchor to cell surfaces. Therefore, alteration 
in the hydrophobicity and surface charge of polymeric constituents are proved 
as efficient for controlling biofilm formation by using numerous antimicrobial 
agents and backbone compounds [13]. Poly N-vinylpyrrolidone and Hydrophilic 
polymers i.e. hyaluronic acid [14] on silicone shunt and polyurethane catheters 
have been widely used to decrease the adherence of ‘Staphylococcus epidermidis’. 
Furthermore, several hydrogel membranes have been introduced particularly 
for ureteral stents that decrease bacterial adherence because of their hydrophilic 
characteristics. It has been observed that due to very low wettability superhy-
drophobic coatings play a significant role to reduce the biofilm matrix formation 
and adhesion of bacteria [15]. Later, it has been suggested that S. aureus and 
Pseudomonas aeruginosa poorly attached on superhydrophobic fluorinated silica 
coating as well as on titanium coatings. However, it was demonstrated that 
Escherichia coli and Staphylococcus aureus poorly adhered on other superhydro-
phobic surfaces i.e. (AACVD) aerosol assisted chemical vapor deposition-coated 
[16]. In some cases, it was observed that hairpin coating affects colonization 
and adhesion of bacteria because it forms vascular catheter negatively charged, 
so contribute to reducing the catheter-related infections, inhibiting microbial 
colonization and thrombosis [17]. It has been described that the surface rough-
ness can modulate hydrophobicity, which ultimately influences the bacterial 
adhesion [18].
3.2 Altering the chemical properties of biomaterials
There are several chemical approaches used to alter the exterior of biomedical 
equipment to inhibit the biofilm formation comprising ion coatings, biocides and 
also antibiotics [19]. Catheters that are impregnated with antibiotics, for example, 
rifampin and minocycline have been revealed to reduce the occurrence of biofilm-
based infections by Staphylococcus aureus. Furthermore, catheters are coated with 
several antibiotics that play a significant role in biofilm production during urinary 
tract infections (UTI) like norfloxacin, nitrofurazone, and gentamicin [20]. Several 
chemical molecules are identified through screening of chemical libraries, these 
molecules are used as potential drugs to control infection and biofilm development. 
Furthermore, such molecules do not provoke antimicrobial action, and hence 
reduces the development of resistance due to no selective pressure against biofilm 
matrix formation. In Staphylococcus aureus and Streptococcus pyogenes a series of 
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small chemical molecules have an inhibitory effect on the expression of different 
important virulent factors during infection and biofilm formation [21]. Several 
aryl rhodamines showed inhibitory effect on early stages of biofilm development 
in Enterococcus faecalis, S. epidermidis, and S. aureus. Moreover, it was reported that 
a mucolytic mediator N-acetylcysteine has inhibited the formation of exopolysac-
charides in the biofilm layer in case of S. epidermidis [22]. In another microorganism 
Vibrio cholerae, small substances suppressed the initiation of cyclic di-GMP that acts 
as the second messenger to control switch in-between the aquatic and sessile way of 
living of microbes [23].
It has been observed that numerous antibacterial peptides also inhibit 
biofilm formation in several microbes. For instance, it is considered that pep-
tide 1018 has inhibitory effects in different microbes such as in Acinetobacter 
baumannii, Burkholderia cenocepacia, Klebsiella pneumoniae, P. aeruginosa, E. 
coli, Salmonella typhimurium and S. aureus [24]. Furthermore, class of peptide 
antibiotics called lantibiotics i.e. gallidermin, epidermin, subtilin, and nisin has 
been reported and control the biofilm production in S. aureus, S. epidermidis and 
also in Lactococcus lactis.
Chelators hindering the role of metal ions in the production of biofilm are 
considered as biofilm inhibitors, for example, silver salts, metallic silver and also 
silver nanoparticles are commonly employed as antibacterial agents in clinical 
implants against P. aeruginosa, Salmonella typhimurium, Klebsiella species, E. coli, 
and S. aureus [25]. It is observed that antibiotics i.e. amoxicillin, clindamycin, 
vancomycin, penicillin G and erythromycin show increased antimicrobial activ-
ity against Staphylococcus aureus in the presence of nanoparticles [26]. Treatment 
with silver substances prevents DNA replication, expression of cellular as well 
as ribosomal proteins, and also respiration process that leads to death of the 
cell [27]. In addition, It is also suggested that silver-coated implants inhibit 
Staphylococcus aureus biofilm production without aggregating silver inside the 
host tissue [28].
4. Quorum quenching
In the majority of Gram-negative and Gram-positive bacteria, an essential 
cellular communicating system is presently called as Quorum sensing, which 
regulates a variety of genes in accordance with the density of signaling molecules 
furthermore, signaling molecules are called autoinducers [29]. On the bases of 
signaling molecules QS is classified into three i.e. autoinducing peptide (AIP-
based) for Gram-positive bacteria, N-acyl homoserine lactones (AHLs-based) for 
Gram-negative bacteria and autoinducer-2 (AI-2-based) for both Gram-negative 
and Gram-positive bacteria [30]. When the biofilm is formed, after the initial 
attachment, cells secrete QS molecules that alter the expression of the microbial 
gene, thus changing planktonic form into a sessile form. Furthermore, QS plays 
a significant role in biofilm development, so It has been observed that QS inhibi-
tion i.e. quorum quenching (QQ ) would be a striking approach to control biofilm 
formation [31]. QS system is thought to be a target for developing new antimi-
crobial agents, moreover, QS system plays a crucial role in regulating pathoge-
netic factors and also virulence factors production in several pathogens [32]. 
The most important benefit of preventing biofilm formation by QQ is that this 
approach decreases the risk of multidrug resistance (MDR) and thus creating 
this approach noticeable to prevent biofilm-based infections in clinical settings. 
The different approaches for the inhibition or removal of biofilms are  
summarized in Table 1 and Figure 1.
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Bacteria Compound Mechanism Antibiofilm activity References
P. aeruginosa N-Acyl homoserine 
lactones
Transcriptional regulators (LuxR and LasR) Decreased the production of QS signals and virulence 
factors
[49]
Patriniae Biofilm related genes Reduced the production of exopolysaccharide [50]
Hordenine Quorum sensing related genes Blocked QS-controlled phenotypes like biofilm formation [51]
Quercetin Transcriptional regulators of quorum sensing 
related genes
Inhibition of biofilm formation [52, 53]
‘Piper betle’ Leaves 
(Ethanolic Extract)
Pyocyanin Inhibited Pyocyanin production and reduced twitching 
ability
[53]
Parthenolide Extracellular polymeric substance and 
transcriptional regulators of quorum sensing 
related genes
Inhibition of the expression of QS related genes expression 
and downregulation of extracellular polymeric substance 
production
[54]
E. coli O157:H7 Ginkgolic acids (GAs) Curli gene expression, prophage genes Biofilm formation was inhibited on the polystyrene, glass 
and nylon membrane
[55]
Phloretin Toxin genes, autoinducer-2 importer genes curli 
genes, prophage genes
Decreased biofilm formation and production of fimbria [55]
Cinnamaldehyde LuxR-DNA-binding Affected the biofilm formation and virulence [56]
S. mutans ‘Zingiber officinale’ 
(Methanolic fraction)
F-ATPase activity, virulence genes, surface 
protein antigen (SpaP)
Affected the cell-surface hydrophobicity index, Inhibited 
surface protein antigen (SpaP)
[57]
Leaf extract of ‘Bergenia 
crassifolia’ (L.)
Exopolysaccharides (EPSs), glucosyltransferases 
(Gtfs)
Decreased adherence properties of bacterial cells [58]
Quercetin pH Disrupted the pH in biofilm [59]
Staphylococcus aureus and 
Staphylococcus epidermidis
‘Rhodomyrtus tomentosa’ 
(Ethanol extract)
Not mentioned Inhibition of biofilm formation and disruption of mature 
biofilm
[60]
S. aureus strains Phloretin Efflux protein genes Anti-biofilm formation at low [61]
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Bacteria Compound Mechanism Antibiofilm activity References
S. aureus and C. albicans ‘Hymenocallis littoralis’ 
leaf extract
Adhesin proteins Antimicrobial and anti-biofilm activity [62]
Streptococcus pneumoniae Quercetin SrtA gene The blockage of SrtA gene function, impairment of biofilm 
formation
[63]
Enterococcus faecalis Quercetin Protein translation and folding pathways Blocked the protein translation and folding pathways [64]
Table 1. 
Anti-biofilm compounds for various clinically important bacteria.
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5. Removal of biofilms
Another anti-biofilm approach is the dissociation of the biofilm matrix which 
accounts for around 90% of biofilm dry mass. This dissociation will ultimately 
expose the sessile bacteria to the antibiotics as well as host immune defense. The 
enzymes majorly employed for biofilm matrix-degradation can be divided into 
three categories Proteases, nucleases and polysaccharide degrading enzymes [33].
Moreover, the surfactants also possess the antibiofilm activities as the cetyltri-
methylammonium bromide (CTAB), sodium dodecyl sulfate (SDS) and Tween 20 
have been found to promote the detachment or dispersal of biofilms. Surfactin; 
a biosurfactant produced by the Bacillus subtilis was shown to inhibit the biofilm 
dispersal in E. coli, Proteus mirabilis, and S. typhimurium [33].
6. Bacteriophages as antibiofilm agents
Bacteriophages are considered as the largest creature in the biosphere, because 
of antibiotic resistance development, bacteriophages play an important role in 
the destruction of microbes. Use of bacteriophages is now considered as an alter-
native strategy to antibiotics, particularly for disruption or biofilm inhibition. 
Bacteriophages are beneficial than chemical agents and antibiotics. The isolation 
of bacteriophage is simple and fast, furthermore, its production is also cheap, and 
these are very distinct against a host or either host range, therefore, do not disrupt 
the normal flora. Bacteriophages are ecologically friendly, so with the persistence of 
host bacteria, they can replicate at the target site and have no adverse effects.
Bacteriophages also considered as potent antibiofilm mediators, e.g., phage T4 
can cause infection and replicates within E. coli biofilms and by destroying micro-
bial cells it can disturb the biofilm matrix. Doolittle and colleagues reported a study 
and demonstrated the interaction of phages with biofilms. The interaction among 
biofilm and phage is a dynamic as well as a sequential process. Phage adsorption 
with the target bacterial receptors is the significant phase in phage infection. The 
EPS matrix suggests a potent challenge for bacteriophages as EPS must be enough 
penetrated so that bacteriophages can attach with and reach to the particular host 
receptors. Furthermore, the EPS matrix also helps in the protection of bacteria in 
the biofilm. Moreover, by diffusion or through phage derived enzymes, for exam-
ple, polysaccharide depolymerase can easily penetrate the EPS layer because these 
enzymes have the ability to destroy the structure of biofilm so that these phages can 
readily anchor to outer membrane receptors, lipopolysaccharides, or other proteins 
that are essential for replication process [34]. It is surely suggested that these phages 
induced depolymerizes can easily disrupt biofilms. Now genetically engineering 
Figure 1. 
An overview of the different anti-biofilm strategies.
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for phages have been introduced that explicit biofilm degrading enzymes during 
infection. The scientist has engineered a gene namely “dispersion” (dspB) into an 
E. coli specific T7 phage to yield an engineered enzymatic phage, which shows more 
efficacy for the removal of biofilms as compared to non-cloned phages.
Despite the several benefits of phage use, there are some disadvantages also, for 
example, the release of a considerable amount of bacterial membrane-bound endo-
toxins, decreased number of phages encoding toxins, insufficient pharmacokinetic 
data and conversion of lytic phages to prophages is also a big concern. Some of the 
above-mentioned problems have been well determined through different processes 
like designing a recombinant phage from Pseudomonas aeruginosa filamentous phage 
to minimize the mortality rate in experimental animals and release of membrane-
bound endotoxins to report the endotoxin release issue is major advances to over-
come the above-mentioned concerns [35]. It has been observed that bacteriophages 
and antibiotics have a big potential to control biofilms such as phage PhilBB-PF 7A 
plays role in the removal of Pseudomonas fluorescens biomass and has shown almost 
63–91% activity.
Different studies show some of the strongest inhibitions, for example, the 
existence of biofilm EPS matrix hindering the control of biofilm via antibacte-
rial agents and higher antibiotic resistance can be controlled through phage use. 
Furthermore, there are many limitations of phage use such as microbial resistance 
to phages, virulence genes that are phage-encoded can incorporate inside the host 
bacterial genome and the narrow host range. Phage efficacy can also be reduced by 
the immune system, and phage preparations that are improperly obtained can also 
contain endotoxin. To control these obstacles engineered phages or phage mixtures 
can be an effective alternative. Moreover, after proper selection and several studies 
phages has become one of the most useful anti-biofilm agents.
7. Natural anti-biofilm strategies
7.1 Plant extracts
Many extracts of plants and their derivatives were widely studied to eliminate 
the ‘Propionibacterium acne’ biofilm [36]. It has been reported that out of 119 plant 
extracts, five showed strong antibiofilm activity i.e. Rhodiola crenulata, Dolichos 
lablab, Malus pumila, Epimedium brevicornum, and Polygonum cuspidatum. These 
scientists also suggested that extracts of P. cuspidatum and E. brevicornum and their 
active derivatives i.e. resveratrol and icartin show a potential antibiofilm activity 
even when used at lowest MIC. Bark extracts of Melia dubia were evaluated with 
30 mg/mL concentration [37]. Furthermore, these extracts exhibit potential sup-
pression of hydrophobicity, swarming motility, hemolysis, and biofilm production 
in E. coli. Other colleagues also reported similar results about Capparis spinosa 
(caper bush) extract, this extract shows inhibitory effect on the EPS production and 
biofilm production in Serratia marcescens, Pseudomonas aeruginosa, Proteus mirabilis, 
and Escherichia coli at 2 mg/mL concentration [38]. In addition, well-known biofilm 
formation of 3 microbes was dispersed. A medically important plant ‘Lagerstroemia 
speciosa’ usually present in Southeast Asia, fruit extract from this plant is capable of 
inhibiting biofilm formation by ‘P. aeruginosa’ PAO1 at 10 mg/mL concentration [39].
Other two plant extracts Dandasa (Juglans regia Tree Bark) and green tea 
(Camellia sinensis) show a potential antibiofilm activity individually. Recently, 
researchers observed that both Green tea and Dandasa exhibit potential antibiofilm 
activity of Streptococcus mutans at 12.5 and 6.2 mg/mL concentration, respectively, 
and on E. coli at 3.1 and 12.5 mg/mL concentration, respectively.
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Allium sativum extract i.e. fresh garlic extract (FGE) has a potential inhibi-
tory effect against biofilm formation, it has been observed that FGE decreased 
‘P. aeruginosa’ biofilm formation [40]. In-vitro screening of antibiofilm activity 
of ‘Staphylococcus epidermidis’ of different 45 aqueous extracts from twenty-four 
Caatinga (Brazilian xeric shrubland) medicinal species was published. Extremely 
favorable extracts were taken from Chamaecrista desvauxii fruits, Pityrocarpa 
moniliformis leaves, Bauhinia acuruana fruits and B. acuruana branches, which show 
decreased the formation of biofilm even when they were tested at the lowest concen-
tration. In addition, it was also suggested that Senna macranthera and Commiphora 
leptophloes fruit extracts decreased biofilms by 66.7% and 67.3% respectively. 
Mycobacterium smegmatis which plays a significant role in biofilm development 
was observed by using many quantitative and qualitative techniques. Other sci-
entists examined different plants i.e. Vaccinium oxycoccos, Hippophae rhamnoides, 
Azadirachta indica and Juglans regia and spices to look for useful antibiofilm natural 
substitutes. When the efficiency of plant extracts as an antibiofilm agent was 
checked it showed that the extract of Azadirachta indica usually named as “Neem” 
was surprisingly helpful at removing and lowering M. smegmatis biofilms [41].
Another plant extract ‘casbane diterpene’ isolated from “Croton nepetaefolius” 
extract, is used to suppress the biofilm production of five Gram-negative bacterial 
species (Klebsiella oxytoca, Klebsiella pneumoniae, Escherichia coli, Pseudomonas 
fluorescens and Pseudomonas aeruginosa), two Gram-positive bacterial species (S. 
epidermidis and S. aureus), and three yeast species (Candida glabrata, Candida 
tropicalis and Candida albicans) [42]. Furthermore, another study demonstrated 
that Candida biofilm formation was remarkably decreased by Boesenbergia pandu-
rata also known as “finger root oil” almost by 63–98% when MIC levels were used 
from 4 to 32 μL/mL [43]. Later studies showed that different plant extracts were 
isolated against Enterohemorrhagic E. coli (EHEC) O157:H7 biofilm. Furthermore, 
this study displayed that out of 498 plant extracts, almost 16 of them showed an 
inhibitory effect on biofilm formation of EHEC above 85% with no-growth of 
planktonic cells [44]. Certainly, these results specify that these different plant 
extracts show maximum inhibitory effect on biofilm formation of several microbes. 
Hence, it is suggested that further efforts are required to study the potential of these 
plant extracts as antibiofilm agents in detail.
7.2 ‘Honey’
A natural product extracted by ‘honey’ bee from floral nectar is called as ‘honey’ 
however, ‘honey’ is generally common and is usually used for its remarkable activ-
ity in wound-healing, anti-inflammatory, and antibacterial activity and used as an 
antioxidant. It has antimicrobial activities against 60 species of fungi and bacteria. 
‘Honey’ was reported as a useful agent to control the biofilm formation. Furthermore, 
it was described that ‘honey’ is effective in the prevention of Enterococcus spp. biofilm 
production and can also use as a therapeutic agent against many Enterococcal infec-
tions that are biofilm-related. It can also decrease the biofilm production of EHEC 
O157:H7. Recent studies show that very low quantity of ‘honey’ can significantly 
decrease the formation of biofilm, the virulence of E. coli O157:H7 and Quorum 
sensing. So, a very low ‘honey’ concentration can decrease the formation of biofilm 
by preventing the virulence genes transfer in microbes and the expression of biofilm-
associated curling QS, without inhibiting the cell growth. Due to its antimicrobial 
properties, high concentration of ‘honey’ can also prevent biofilm formation as 
well as adhesion of bacteria. Despite its antibacterial activity, it is also observed that 
‘honey’ inhibits biofilm formation by antibacterial peptide which is bee defensin 1 
that prevents microbial viability as well as biofilm formation indirectly [41].
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7.3 Essential oils
Naturally plant-derived volatile substances are called as essential oils (EOs). 
Because of their antibacterial and preservative properties, these are effective and 
favorable natural products for the food industry. These essential oils are commonly 
used against a wide diversity of microorganisms since ancient time. These oils 
exhibit antimicrobial impact on the cell wall of microbes, leading to the destruction 
of microbes. Furthermore, it is suggested that these oils are very effective in inacti-
vating many microbes without producing antimicrobial resistance [45]. Because of 
little mammalian toxicity, rapid degradation in the environment and availability of 
many essential oils make them beneficial antibiofilm agent [46].
Cumin oil scientifically named Cuminum cyminum, a derivative of an aromatic, 
therapeutic plant of “Apiaceae” family, has various medicinal properties and in the 
digestive system, it acts as an astringent. It has been widely used for acute gastric 
diseases as a carminative and eupeptic, and as an analgesic. It is also widely used 
to flavor foods, for example, added in food for fragrance. Cumin seeds have been 
used since ancient time. The efficiency of cumin seed against biofilm development 
on Klebsiella pneumoniae strains was observed, which showed that cumin seeds has 
decreased biofilm activity with improved ciprofloxacin efficiency [47].
Cinnamon oil is derived from the inner bark of the “Cinnamomum zeylanicum’ 
as well as “Cinnamomum cassia” and is mostly used in the food industry due to its 
specific fragrance [48]. It is suggested that this oil is efficient against biofilm cul-
tures Lactobacillus plantarum, S. mutans, and S. epidermidis. Oregano also is known 
as Origanum vulgare has inhibitory activity on biofilm production in case of E. coli 
and Staphylococci. A study revealed that Oregano essential oil exerts antimicrobial 
action on E. coli, S. haemolyticus, S. sciuri, S. aureus, and S. lugdunensis and could 
prevent biofilm formation. Moreover, it also able to detach active biofilm even at 
very low MIC. Inhibitory activity of “Brazil nut oil” named as Bertholletia excelsa (a 
vegetable oil) on commercially available dentifrice to prevent dental biofilm was 
also assessed. Scientists showed that by adding this vegetable oil to commercially 
available dentifrice, dental biofilm formation can be inhibited. Furthermore, this 
oil helps in preventing and controlling periodontal diseases [41].
The antimicrobial activity of “tea tree” essential oils scientifically named 
Melaleuca alternifolia, synergistically with ciprofloxacin was also evaluated against 
‘P. aeruginosa’ biofilms. The consequences showed that the combined effect of TTO 
with ciprofloxacin has decreased biofilm biomass significantly by more than 70% 
and lowered the number of cells at the lowest (1.25 μg/mL) ciprofloxacin concentra-
tion. The efficacy of essential oils from cinnamon (Cinnamomum verum), namely 
thymol, and oregano at sub-lethal concentrations on biofilm formation of 3 biofilm-
forming bacterial strains i.e. Stenotrophomonas, Acinetobacter and Sphingomonas 
were assessed. Researchers showed that at the MIC, two out of three strains revealed 
resistance on microbial biofilm formation. Furthermore, among the three tested 
oils, “thyme oil” was considered as more efficient and showed inhibitory effect even 
on sub-lethal concentrations of 0.001% (w/v) [41].
8. Conclusion
Since biofilms are abundant in nature, the importance of biofilms in hospitals 
especially regarding their role in infections is often undervalued. Future studies 
should attempt to comprehend the biological forces controlling the colonization 
to develop innovative strategies for controlling biofilm biomass within a clinical 
context. Additionally, comprehensive research is required to recognize the potential 
11
Innovative Strategies for the Control of Biofilm Formation in Clinical Settings
DOI: http://dx.doi.org/10.5772/intechopen.89310
of various synthetic and natural quorum sensing inhibitors (QSIs) for their 
applicability for humans. As these QSIs do not encourage the antibiotic resistance, 
therefore they can surely be the future therapeutic agents for the management of 
biofilm-based bacterial infections in clinical settings.
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